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Background: The treatment of leishmaniasis with pentavalent antimonials is problematic because of their toxicity.
Investigations of potentially active molecules are important to discover less toxic drugs that are viable economic
alternatives for the treatment of leishmaniasis. Thiosemicarbazones are a group of molecules that are known
for their wide versatility and biological activity. In the present study, we examined the antileishmania activity,
mechanism of action, and biochemical alterations produced by a novel molecule, 4-nitrobenzaldehyde
thiosemicarbazone (BZTS), derived from S-limonene against Leishmania amazonensis.
Results: BZTS inhibited the growth of the promastigote and axenic amastigote forms, with an IC50 of 3.8 and
8.0 μM, respectively. Intracellular amastigotes were inhibited by the compound with an IC50 of 7.7 μM. BZTS also
had a CC50 of 88.8 μM for the macrophage strain J774A1. BZTS altered the shape, size, and ultrastructure of the
parasites, including damage to mitochondria, reflected by extensive swelling and disorganization of the inner
mitochondrial membrane, intense cytoplasmic vacuolization, and the presence of concentric membrane structures
inside the organelle. Cytoplasmic lipid bodies, vesicles inside vacuoles in the flagellar pocket, and enlargement
were also observed. BZTS did not induce alterations in the plasma membrane or increase annexin-V fluorescence
intensity, indicating no phosphatidylserine exposure. However, it induced the production of mitochondrial
superoxide anion radicals.
Conclusions: The present results indicate that BZTS induced dramatic effects on the ultrastructure of L. amazonensis,
which might be associated with mitochondrial dysfunction and oxidative damage, leading to parasite death.
Keywords: Antileishmanial activity, Benzaldehyde thiosemicarbazone, Leishmania amazonensis, Ultrastructural
alterations, Mitochondria damage, Electron microscopy, Cellular disorganizationBackground
Leishmaniasis represents a serious public health problem
in 88 countries, occurring mainly in economically disad-
vantaged regions [1]. Few drug therapy discoveries have
been made in recent decades. The first-line treatment for
cutaneous leishmaniasis consists of only pentavalent anti-
monials, but their toxicity is a major issue [2]. Although* Correspondence: cvnakamura@uem.br
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unless otherwise stated.these drugs are not an ideal treatment, none of the other
many investigated drugs are better than pentavalent anti-
monials with regard to safety, efficacy, and cost [3,4]. In-
vestigations of potentially active molecules are important
to discover less toxic drugs that are viable economic alter-
natives for the treatment of leishmaniasis.
Thiosemicarbazones are a group of molecules whose
biological properties have long been investigated [5].
Antiviral, antiprotozoal, antitumor, antimicrobial, and
antifungal properties have been reported for some thiose-
micarbazones [6,7]. Phase 2 clinical trials that investigatedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 Structure of 4-nitrobenzaldehyde thiosemicarbazone
derived from S-limonene.
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known as Triapine, were completed for the treatment
of metastatic renal cell carcinoma, and patients are cur-
rently being recruited for Phase 2 clinical trials for vagi-
nal cancer [8,9].
Thus, this chemical group is known for its wide versa-
tility and biological activity, which is mainly associated
with a metal complex or the presence of different sub-
stituent groups, such as limonene. These purposeful
molecular changes appear to improve the biological
properties of the molecule, increase the potential for ac-
tivity, and lessen cytotoxicity in an attempt to reach a
specific target in the parasite, such as mitochondria
[10-12]. The main cellular targets of some thiosemicar-
bazones have been previously reported, indicating from
molecular and chemistry targets, such as viral RNA syn-
thesis and tyrosinase activity respectively, to organelles
dysfunction, like mitochondria function [13-15]. The
present study examined the antileishmania activity and
mechanism of action of a novel molecule, 4-nitroben
zaldehyde thiosemicarbazone, derived from S-limonene
against L. amazonensis.
Results
BZTS inhibited L. amazonensis proliferation in vitro
To determine the effects of BZTS (Figure 1) on the cellu-
lar proliferation of L. amazonensis, the parasites were in-
cubated with BZTS (2.7, 13.9, 27.7, 139 and 277 μM) for
72 h. BZTS dose-dependently inhibited the growth of the
promastigote and axenic amastigote forms, with an IC50
of 3.8 μM and 8.0 μM, respectively. BZTS exerted activ-
ity against intracellular amastigotes at an IC50 value of
7.7 μM. BZTS was also evaluated for its cytotoxic effects
on the macrophage strain J774A1, with a CC50 of
88.8 μM. Cytotoxicity in J774A1 macrophages and activ-
ity against promastigotes, axenic amastigotes, and intra-
cellular amastigotes were compared using the selectivity
index (SI; ratio: CC50 J774A1 macrophage/IC50 protozoa).
The observed SIs were 23.4, 11.1, and 11.5 for the promas-
tigotes, axenic amastigotes, and intracellular amastigotes,
respectively. These results demonstrate that BZTS is more
toxic to the protozoa than to macrophages (Additional
files 1, 2, and 3).
BZTS induced morphological and ultrastructural changes
Scanning electron microscopy revealed that BZTS caused
morphological alterations in the promastigote forms of L.
amazonensis compared with untreated parasites, which
showed typical characteristics, with an elongated shape
and free flagellum. Figure 2 shows alterations in shape and
size and cellular disintegration in BZTS-treated parasites.
These alterations were more pronounced in parasites
treated with the IC90 (13.9 μM) of BZTS. To evaluate the
alterations in cell shape and size in promastigote formsrevealed by SEM, the treated parasites were assessed by
flow cytometry. The histogram showed that BZTS-
treated parasites exhibited a reduction of parasite volume
(Figure 3). A dose-dependent decrease in cell volume was
observed (32.3%, 83.8%, 86.3%, and 89.3% at BZTS con-
centrations of 55, 139, 277, and 555 μM, respectively).
Transmission electron microscopy of BZTS-treated pro-
mastigotes and axenic amastigotes showed the presence of
several ultrastructural alterations (Figures 4 and 5). BZTS
induced severe damage in parasite mitochondria, reflected
by extensive swelling and disorganization in the inner
mitochondrial membrane, intense cytoplasmic vacuoli-
zation, and the presence of concentric membrane stru-
ctures inside the organelle. Cytoplasmic lipid bodies,
vesicles inside vacuoles in the flagellar pocket, and en-
largement were also observed.
To confirm the accumulation of lipid bodies in treated
promastigotes observed by TEM, we evaluated the exist-
ence of this structure using Nile Red staining, which stains
neutral lipids. Fluorescence microscopy revealed the pres-
ence of lipid bodies in control promastigotes, but the pres-
ence of lipid bodies was enhanced after treatment with the
IC50 and IC90 of BZTS for 72 h (Figure 6). This structure
Figure 2 Scanning electron microscopy of Leishmania amazonensis promastigotes. The figure shows control promastigotes (A) and
promastigotes treated with concentrations that corresponded to the IC50 (B-D) and IC90 (E,F) of BZTS. (A) The protozoan presented typical
characteristics, with an elongated shape and free flagellum. (B-F) BZTS induced alterations in the shape and size of the protozoan. Scale bar = 1 μm.
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parasite cytoplasm.
BZTS altered ΔΨm but not cell membrane integrity
Alterations in cell membrane integrity were evaluated
by PI staining, which is a nucleic acid stain that pene-
trates cells with a compromised plasma membrane and
does not cross the membranes of live cells. BZTS-
treated, PI-labeled promastigotes did not show signifi-
cant permeabilization of the plasma membrane com-
pared with untreated parasites. BZTS at concentrations
of 55, 139, 277, and 555 μM showed PI fluorescence in-
tensity of 5.3%, 7.7%, 11.3%, and 12.7%, respectively.
The negative control showed PI fluorescence intensity
of 4.2%, and the positive control (digitonine) showed PI
fluorescence intensity of 47.3% (Figure 7).
Transmission electron microscopy demonstrated that
BZTS induced alterations in parasite mitochondria, and
we evaluated the ΔΨm by flow cytometry using Rh 123,
which accumulates within energized mitochondria. The
histograms (Figure 8) revealed a decrease in total Rh 123
fluorescence intensity, indicating mitochondrial mem-
brane depolarization. BZTS at concentrations of 55, 139,
277, and 555 μM caused 46.2%, 77.3%, 78.5%, and 72.4%
decreases in total Rh 123 fluorescence intensity, respect-
ively, compared with the negative control. Such decreaseswere further quantified as IV values. Promastigotes that
were treated with 55, 139, 277, and 555 μM BZTS had IV
values of −0.46, −0.77, −0.78, and −0.72, respectively.
BZTS did not induce phosphatidylserine exposure
Phosphatidylserine (PS) is a phospholipid that is confined
to the inner face of the plasma membrane and translo-
cates to the cell surface in apoptotic cells. Annexin V is a
calcium-dependent, phospholipid-binding protein that
preferentially binds PS (1, 26, 29). Annexin V-FITC was
used to evaluate the externalization of phosphatidylserine.
As shown in Figure 9, no significant increase in annexin-V
fluorescence intensity was observed compared with un-
treated parasites, indicating no phosphatidylserine ex-
posure. The histograms showed annexin-V fluorescence
intensity of 12.4%, 11.9%, 13.9% and 14.2% at BZTS con-
centrations of 55, 139, 277, and 555 μM, respectively. The
negative control showed annexin-V fluorescence intensity
of 8.6%. The positive control (CCCP) showed a 71.6% in-
crease in annexin-V fluorescence intensity.
BZTS caused mitochondrial O2
•ˉ production
After observing severe damage in parasite mitochondria
and mitochondrial membrane depolarization, we evalu-
ated the production of O2
•ˉ. Mitochondrion-derived O2
•ˉ
production was evaluated using MitoSOX reagent, which
Figure 3 Cell volume analysis by flow cytometry of untreated
Leishmania amazonensis promastigotes (A) and promastigotes
treated with 55, 139, 277, and 555 μM BZTS, respectively (B-E),
after 24 h of incubation at 25°C. SSC-H, side scatter; FSC-H,
forward scatter.
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based on its hydrophobic nature and positively charged
triphenylphosphonium moiety. MitoSOX oxidation was
higher in BZTS-treated parasites compared with controls.
The increase in MitoSOX oxidation in BZTS-treated pro-
mastigotes was observed after 1 h of incubation. Treat-
ment with 277 and 555 μM caused higher MitoSOX
oxidation than the lower concentrations (Figure 10).
Discussion
Drug therapy for leishmaniasis has not significantly
changed since the beginning of the 20th century, and ad-
equate treatment remains a problem because of toxicity
and side effects. New treatments that are more effective
and less toxic are urgently needed [16]. Investigations of
new drugs with antileishmanial activity, including both
natural products and synthetic compounds, have been
performed worldwide [17-21].
In the present study, we showed that BZTS had anti-
proliferative effects on promastigotes and axenic amasti-
gotes, with a reduction of survival of intracellular parasites
in macrophages. Moreover, BZTS was more selective for
the protozoa than for mammalian cells. BZTS exerted its
antileishmanial activity by affecting parasite mitochondrial
function, indicated by TEM, variations in ΔΨm by flow
cytometry using Rh 123, and the production of O2
•ˉ evalu-
ated by MitoSOX oxidation.
The single mitochondrion of the kinetoplastid parasite
is an attractive chemotherapeutic target because its func-
tional features are markedly distinct from mammalian
mitochondria [22]. Our previous studies showed the
in vitro antileishmanial activity of benzaldehyde thiose-
micarbazone derived from limonene complexed with
copper against L. amazonensis, with an effect on mito-
chondrial function [13]. Inácio et al. (2012) reported that
epigallocatechin-3-gallate induced death in L. amazonensis
by directly affecting mitochondrial physiology in treated
parasites. These effects were detected as ultrastructural al-
terations of the mitochondria, organelle injury, and a de-
crease in Rh 123 fluorescence. Monzote et al. (2014) [23]
suggested that the antileishmania activity of the essential
oil and major constituents (i.e., ascaridole, carvacol, and
caryophllene oxide) of Chenopodium ambroisiodes against
L. amazonensis promastigotes is correlated with mito-
chondrial dysfunction, reflected by ΔΨm. Further studies
by our group demonstrated ultrastructural mitochondrial
alterations and ΔΨm changes in parasites treated with
thiophene derivatives isolated from the aerial parts of
Figure 4 Ultrathin sections of Leishmania amazonensis promastigotes without treatment that presented a normal ultrastructure (A)
and promastigotes treated with BZTS at concentrations that corresponded to the IC50 (B-D) and IC90 (E, G). White arrows indicate swollen
mitochondria. Black arrows represent lipid-storage bodies. White arrowheads indicate the presence of vesicles inside the flagellar pocket. The star
indicates the presence of concentric membranous structures. n, nucleus; m, mitochondrion; k, kinetoplast; f, flagellum; fp, flagellar pocket. Scale
bar = 1 μm.
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1-[4-dimethylamino]phenyl-1,2,3,4-tetrahydro-β-carbo-
line-3-carboxamide), and eupomatenoid-5, a neolignan
isolated from the leaves of Piper regnellii [24-27]. Luque-
Ortega et al. (2010) [28] also showed that benzophenone-
derived bisphosphonium salts present antileishmania
activity against promastigotes of the Leishmania dono-
vani causing a dramatically swollen mitochondrion in
treated parasites, and a decrease of the electrochemical
mitochondrial potential.Mitochondrial changes may be a consequence of many
harmful effects induced by endogenous toxic compounds,
such as reactive oxygen species (ROS). BZTS induced the
production of these compounds, which may be respo-
nsible for mitochondrial injury and the induction of
oxidative damage in lipids and proteins, reflected by
variations in ΔΨm using Rh 123 and the production
of O2
•ˉ. These results are similar to those reported
by Volpato et al. (2013) and Desoti et al. (2012) [29],
in which Trypanosoma cruzi were treated with N-butyl-
Figure 5 Ultrathin sections of Leishmania amazonensis axenic amastigotes without treatment that presented a normal ultrastructure
(A) and treated with BZTS with concentrations that corresponded to the IC50 (B-F) and IC90 (G,I). White arrows indicate swollen mitochondria.
Black arrows represent lipid-storage bodies. White arrowheads indicate the presence of vesicles inside the flagellar pocket. The star indicates the
presence of concentric membranous structures in the mitochondria. The asterisk indicates autophagic vacuoles. n, nucleus; m, mitochondrion; k,
kinetoplast; f, flagellum; fp, flagellar pocket. Scale bar = 1 μm.
Figure 6 Differential interference contrast microscopy (DIC) and fluorescence microscopy with Nile Red staining of Leishmania
amazonensis promastigotes without treatment (A, B) and treated with concentrations that corresponded to the IC50 (C-F) and IC90 (G-L)
of BZTS for 48 h. In the treated promastigotes, the images suggest the concentration-dependent accumulation of lipid-storage bodies in the
cytoplasm. (G, I, K) The parasites that were treated with the IC90 of BZTS were completely modified. Scale bar = 10 μm.
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Figure 7 Leishmania amazonensis promastigotes treated with BZTS and stained with propidium iodide (PI). (A) Untreated promastigotes.
(B) Promastigotes treated with 40.0 μM digitonine. (C-F) Promastigotes treated with 55, 139, 277, and 555 μM BZTS. The percentage of PI-positive
cells is shown in the upper left quadrant.
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line-3-carboxamide and (−)-elatol extracted from the
red macroalgae Laurencia dendroidea, respectively. This
effect was also reported by Medina et al. (2012), in
which L. amazonensis promastigotes were treated with
tomatidine.
Electrons move through the mitochondrial respiratory
chain during oxidative phosphorylation, and a protonFigure 8 Rhodamine 123-labeled mitochondrial membrane
potential assay by flow cytometry. The figure shows untreated
Leishmania amazonensis promastigotes (negative control [NC]),
promastigotes treated with 55, 139, 277, and 555 μM BZTS, and
promastigotes treated with CCCP (positive control). FL1-H, rhodamine
123 fluorescence.gradient is established across the inner mitochondrial
membrane as an energy source for adenosine triphos-
phate (ATP). A decrease in Rh 123 fluorescence intensity
suggests an increase in proton permeability across the
inner mitochondrial membrane, which can decrease
ATP synthesis and result in parasite death [22,30]. In the
present study, we can infer that this process occurred,
based on the Rh 123 assays. Furthermore, an association
was observed between multivesicular bodies and mito-
chondrion profiles, likely indicating an autophagic process
that removes damaged organelles. In the present study,
TEM indicated the presence of several vesicles.
Mitochondrial ultrastructural alterations, the reduction
of ΔΨm, and the increase in ROS production caused by
BZTS may be explained by calcium release from mito-
chondria, indicating a direct action of BZTS on the or-
ganelle and the inhibition of sterol biosynthesis, leading
to alterations in the lipid composition of mitochondrial
membranes that can modify mitochondrial function
[31,32]. Recently, Shioji Tiuman et al. (2014) [33] dem-
onstrated that when the amastigotes were treated with
parthenolide, a lipophilic hydrocarbon compound formed
by units of isoprene, revealed mitochondrial damage, sug-
gesting that this compound interferes with the mitochon-
drial membrane potential leading to alteration of ATP
generation and in consequence cell damage takes place.
Another important effect of BZTS on parasites was
the accumulation of intracellular lipid bodies in the cyto-
plasm indicated by fluorescence microscopy. The analysis
Figure 9 Phosphatidylserine exposure in untreated Leishmania amazonensis promastigotes (A), promastigotes treated with 100.0 μM
CCCP as the positive control (B), and promastigotes treated with 55 μM (C), 139 μM (D), 277 μM (E), and 555 μM (F) BZTS for 24 h
using annexin-V FITC and PI.
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trast microscopy revealed alterations in shape, principally
by treatment with the IC90 of BZTS, showing a rounded
shape and evidence of the loss of cytoplasmic content.
Similar results were reported by Macedo-Silva et al.
(2011), in which promastigote forms were treated withFigure 10 Mitochondrial O2
− production in Leishamania amazonensis p
to 3 h using the fluorescence probe MitoSOX. Antimycin A (10 μM) wa
X3 spectrofluorometer (Perkin-Elmer). The results are expressed as the mea
independent experiments. *p≤ 0.05, significant difference from negative coamiodarone, an antiarrhythmic drug used for the treat-
ment of Chagas’ disease. The presence of intracellular
lipid bodies may indicate alterations in phospholipids
and sterol content [30,34].
BZTS did not significantly increase annexin-V flu-
orescence intensity in treated parasites, indicating noromastigotes treated with 55, 139, 277, and 555 μM BZTS for up
s used as a positive control. Fluorescence was measured with a VICTOR
n ± standard error of MitoSOX oxidation (arbitrary units) from three
ntrol group.
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BZTS induced several alterations in the mitochondrial
ultrastructure and shape of the parasite. The mitochon-
dria exhibited intense swelling, with the loss of matrix
content, the presence of concentric membranes, inner
membrane disorganization, severe changes in the mito-
chondrial membrane potential, the reduction of cell
volume, and ROS production. These observations may
indicate parasite death caused by apoptosis. Shivahare
et al. (2014) [35] showed that a chromenochalcone
exhibited leishmanicidal effects against Leishmania
donovani by causing loss in membrane potential and
phosphatidylserine exposure, thus exerting cell death
via apoptosis in treated promastigotes.
However, the hypothesis of an autophagic process can-
not be discarded because the presence of autophagic
vacuoles, increases in the number of lipidic inclusions,
and presence of concentric membranes in the cytoplasm
are characteristic of autophagic processes and may be
associated with the accumulation of aberrant lipids that
are probably not entirely incorporated into the plasma
membrane or the membranes that line the various cellu-
lar organelles [36].
Conclusion
Our results demonstrated that BZTS has potent antipro-
liferative activity against different evolutive forms of
Leishmania amazonensis and induced marked effects on
the morphology and ultrastructure of this parasite, such
as interference with various cellular processes that led to
changes in shape and mitochondrial function, the accu-
mulation of lipid droplets, and features found in cells
that die from apoptotic or autophagic processes.
Methods
Chemistry
All of the melting points were determined using a
Microquímica model MQAPF-301 apparatus. Infrared
spectra were obtained using KBr pellets in an FT-IR
BOMEM spectrophotometer. Nuclear magnetic resonance
(1H NMR and 13C NMR) spectra were obtained using a
Varian Mercury Spectrometer (300 MHz for 1H and
75.5 MHz for 13C) in CDCl3/TMS solution at 298°C, with
chemical shifts (δ) given in parts per million. Optical ro-
tation was determined using a Perkin Elmer Model 343
polarimeter at 20°C and 589 nm, with chloroform as the
solvent.
Synthesis of 4-nitrobenzaldehyde thiosemicarbazone
derived from S-limonene
For the synthesis of 4-nitrobenzaldehyde thiosemicar-
bazone, a drop of solution of 5% sulfuric acid and
1.0 mmol (227.4 mg) thiosemicarbazide derived from S-
limonene were added to a flask that contained 1.0 mmol(151.2 mg) 4-nitrobenzaldehyde solubilized in ethanol
(30 ml) (Yamaguchi et al., 2009) [37]. The mixture was
stirred at room temperature for 30 min, and the pro-
gression of the reaction was monitored by TLC. The
solvent was evaporated under reduced pressure, and the
crude product was recrystallized from a mixture of etha-
nol:chloroform (1:3) to yield yellow crystals: yield (93%);
melting point (165.4°C); optical rotation (α20D ): −30.0° [IV
(KBr, υ max): 3325 (NH); 3291 (NH); 2990–2900 (CH);
1544 (C = S); 1373 (C =N). 1H NMR (300 MHz, CDCl3):
δ = 1.57 (s, 3H, H8’); 1.60 (s, 3H, H9’); 1.67 (s, 3H, H10’);
1.86 (m, 2H, H6’); 2.04 (m, 2H, H2’); 2.07 (m, 2H, H5’); 2.69
(m, 1H, H1’); 5.40 (m, 1H, H3’); 7.56 (sl, 1H, H4); 7.75 (dd,
J = 8.7; 4.2 Hz, 2H, H3”/H7”); 7.92 (s, 1H, H1”); 8.27 (dd,
J = 8.7; 4.0 Hz, 2H, H4”/H6”); 9.83 (sl, 1H, H2); 13C NMR
(75.5 MHz, CDCl3): δ = 23.3 (C10’); 23.9 (C9’); 24.1 (C8’);
24.2 (C6’); 26.5 (C2’); 31.0 (C5’); 40.8 (C1’); 59.1 (C7’); 120.2
(C3’); 124.1 (C4”/C6”); 127.5 (C3”/C7”); 134.1 (C4’); 138.5
(C1”); 139.7 (C2”); 148.2 (C5”); 175.1 (C3)] (Figure 1).
Parasite culture
Leishmania amazonensis promastigotes (MHOM/BR/
Josefa) were maintained at 25°C in Warren’s medium
[brain-heart infusion plus hemin (10 μg/mL) and folic
acid (10 μg/mL), pH 7.2] supplemented with 10% heat-
inactivated fetal bovine serum (FBS; Gibco Invitrogen,
New York, NY, USA). Axenic amastigotes were obtained
by in vitro transformation of infective promastigotes by
a progressive temperature increase and pH decrease.
These forms were maintained in Schneider’s medium
(Sigma, St. Louis, MO, USA), pH 4.6, that contained 20%
FBS at 32°C.
In vitro antiproliferative assay
Promastigotes in the logarithmic phase (1 × 106 para-
sites/ml) were grown in 24-well culture microplates at
25°C in Warren’s medium supplemented with 10% FBS,
and axenic amastigote forms (1 × 106 parasites/ml) were
grown in 12-well culture microplates at 32°C in Schnei-
der’s medium supplemented with 20% FBS. The para-
sites were incubated in the presence or absence of 2.7,
13.9, 27.7, 139, and 277 μM BZTS and incubated for
72 h. Dimethyl sulfoxide (DMSO) was used to solubilize
the stock solution of the compound. The final DMSO
concentration did not exceed 1%, which has no deleteri-
ous effects on the parasites. Antileishmania activity was
determined by directly counting free-living parasites in a
Neubauer chamber, and the concentration that inhibited
growth by 50% (IC50) was determined graphically by plot-
ting the concentration vs. percentage growth inhibition.
Activity against intracellular amastigotes
Peritoneal macrophages were collected from BALB/c mice
by washing with cold phosphate-buffered saline (PBS)
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by the Ethical Committee of the State University of
Maringa. Approval no. 074/2011). Sterile glass cover-
slips were placed in the wells of a 24-well microplate,
and 5 × 105 cells/ml were added to each well in RPMI
1640 medium supplemented with 10% FBS. The micro-
plate was incubated for 2 h at 37°C in a 5% CO2-air mix-
ture to adhere macrophages. The macrophage monolayer
was infected with promastigote forms at a 7:1 parasite:
macrophage ratio. After 4 h of interaction at 34°C in a 5%
CO2-air mixture, the microplate was washed with RPMI
1640 medium to remove the non-interiorized parasites.
Afterward, the infected macrophages were treated with
BZTS at concentrations of 2.7, 5.5, 13.9, and 27.7 μM
and incubated for 48 h. The percentage of infected mac-
rophages was evaluated after Giemsa staining by mic-
roscopically counting the number of amastigotes per
macrophage.In vitro cytotoxicity assay
The J774A1 macrophage cell monolayer was suspended
to yield 5 × 105 cells/ml in RPMI 1640 medium supple-
mented with 10% FBS and added to each well in 96-well
microtiter plates. The plates were incubated in a 5%
CO2-air mixture at 37°C to obtain confluent cell growth.
The macrophage monolayer was treated with different
concentrations of BZTS (2.7, 13.9, 27.7, 139, and
277 μM) for 48 h. After treatment, the medium was re-
moved, and the macrophage monolayer was washed with
PBS, and 50 μL of MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide formazan; 2 mg/mL)
was added. The microplate was then incubated for 4 h
in a 5% CO2-air mixture at 37°C. After the incubation
period, 150 μl DMSO was added, and the microplate
was homogenized. Absorbance was read in a microplate
reader (BIO-TEK Power Wave XS) at 570 nm. The per-
centage of viable macrophages was calculated compared
with controls (i.e., macrophages cultured in medium
without drug). The 50% cytotoxic concentration (CC50) was
determined by logarithm regression analysis of the data.Electron microscopy
Scanning electron microscopy
For the morphological analysis, promastigotes that were
treated for 72 h at 25°C with concentrations that corre-
sponded to the IC50 and IC90 for BZTS were fixed in
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer
for 1–3 h. Subsequently, parasites were adhered on poly-
L-lysine-coated coverslips and dehydrated in an ascending
series of ethanol. The samples were critical-point-dried in
CO2, coated with gold, and observed in a Shimadzu SS-
550 scanning electron microscope.Transmission electron microscopy
Ultrastructural analysis was performed with promasti-
gote and axenic amastigote forms that were treated for
72 h at 25°C and 32°C with concentrations that corre-
sponded to the IC50 and IC90 for BZTS, respectively.
After washing with PBS, the parasites were fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer at 4°C
and post-fixed in a solution that contained 1% osmium
tetroxide, 0.8% potassium ferrocyanide, and 5 mM cal-
cium chloride. The parasites were dehydrated in an acet-
one series and embedded in Epon resin for 72 h at 60°C.
Ultrathin sections were stained with 5% uranyl acetate
and lead citrate and examined in a JEOL JEM 1400
transmission electron microscope.
Flow cytometry
Evaluation of cell membrane integrity
Promastigotes were exposed to 55, 139, 277, and
555 μM BZTS for 24 h at 25°C and then harvested and
washed with PBS. The cells were incubated with 50 μl of
2 mg/ml propidium iodide (PI) for 5 min according to
the manufacturer’s instructions. Immediately thereafter,
the cells were analyzed using a BD FACSCalibur flow
cytometer equipped with CellQuest Pro software. A total
of 10,000 events were acquired in the region that corre-
sponded to the parasites. Alterations in PI fluorescence
were determined compared with untreated parasites.
Digitonine (40.0 μM) was used as a positive control.
Determination of mitochondrial transmembrane potential
(ΔΨm)
Promastigotes were exposed to 55, 139, 277, and
555 μM BZTS for 24 h at 25°C. The cells were then in-
cubated with 1 μl (5 mg/ml in ethanol) of rhodamine
123 (Rh 123; Sigma-Aldrich, St. Louis, MO, USA) for
15 min, resuspended in 0.5 ml PBS, and incubated for
an additional 30 min. The assay was conducted according
to the manufacturer’s instructions. The parasites were
analyzed using a BD FACSCalibur flow cytometer and
CellQuest Pro software. A total of 10,000 events were
acquired in the region that corresponded to the parasites.
Carbonyl cyanide 3-chlorophenylhydrazone (CCCP;
100.0 μM) was used as a positive control. Alterations
in Rh 123 fluorescence were quantified using an index
of variation (IV) obtained from the equation (Mt - Mc)/
Mc, in which Mt is the median fluorescence for the BZTS-
treated parasites, and Mc is the median fluorescence for
the untreated parasites. Negative IV values correspond to
depolarization of the mitochondrial membrane.
Detection of phosphatidylserine exposure by annexin-V-FITC
labeling
Promastigotes were treated with BZTS (55, 139, 277 and
555 μM) for 24 h at 25°C and then harvested and washed
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binding buffer (140 mM NaCl, 5 mM CaCl2, and 10 mM
HEPES-Na, pH 4.7), followed by the addition of 5 μl of
FITC-conjugated annexin V. The reaction was incubated
for 5 min at room temperature. Afterward, 400 μl of bind-
ing buffer and 50 μl PI were added. Fluorescence was
measured using a BD FACSCalibur flow cytometer and
CellQuest Pro software. A total of 10,000 events were ac-
quired in the region that corresponded to the parasites as
described above. CCCP (100.0 μM) was included as a
positive control, and untreated parasites served as the
negative control. The parasites were considered necrotic
when they were PI-positive and apoptotic when stained
with annexin-V (PI-positive or -negative).
Determination of cell volume of parasites
Promastigotes were treated with BZTS (55, 139, 277, and
555 μM) for 24 h at 25°C and then harvested and washed
with PBS. The parasites were then analyzed using a BD
FACSCalibur flow cytometer and CellQuest Pro software.
Density plots of forward (FSC) vs. side (SSC) scatter repre-
sent the acquisition of 10,000 events.
Fluorimetric detection of mitochondrial superoxide anion
radical (O2
•ˉ)
Promastigotes were harvested and washed with Krebs-
Henseleit (KH) solution buffer, pH 7.3, that contained
15 mM NaHCO3, 5 mM KCl, 120 mM NaCl, and 0.7
and 1.5 mM NaH2PO4. The cells were loaded with
2.0 ml of 5 μM MitoSOX reagent (3,8-phenanthridine-
diamine-5-[6-triphenylphosphoniumhexyl]-5,6-dihydro-
6-phenyl). The parasites were incubated for 10 min at
37°C and protected from light. After incubation with
MitoSOX reagent, the parasites were washed three times
with KH buffer and treated with 55, 139, 277, and 555 μM
BZTS. Antimycin A (10 μM) was used as a positive
control. MitoSOX detection was performed using black
96-well plates for 3 h. Fluorescence was measured at
excitation and emission wavelengths of 510 and 580 nm,
respectively, in a VICTOR X3 spectrofluorometer
(Perkin Elmer). The results are expressed as arbitrary
units of MitoSOX.
Detection of cytoplasmic lipid bodies by nile red staining
Promastigote forms of L. amazonensis were treated with
concentrations that corresponded to the IC50 and IC90
for BZTS as described previously in an antiproliferative
assay. The treated parasites were then harvested, washed
twice in PBS, and directly stained with 10 μg/ml Nile
Red (Sigma-Aldrich, St. Louis, MO, USA) for 30 min at
room temperature. The cytoplasmic lipid bodies in the
parasites were detected with an epifluorescence micro-
scope (Olympus BX51) equipped with a WG filter. Theparasites were photographed using an Olympus UC30
camera.
Statistical analysis
In the cellular experiments, the 50% growth inhibition
value (IC50) was determined from the linear concentration-
response curves, and the results are expressed as the mean
and standard deviation of at least three independent exper-
iments. Nonparametric data were analyzed using one-way
analysis of variance (ANOVA), and significant intergroup
differences were analyzed using Tukey’s test. All of the
statistical analyses were performed at the p < 0.05 level
of significance.
Additional files
Additional file 1: Graphical 1. Inhibition percentage of promastigote
and axenic amastigote forms of Leishmania amazonensis treated with
BZTS for 72 h. The data are expressed as the means from three
independent tests.
Additional file 2: Graphical 2. Inhibition percentage of intracellular
amastigote forms of Leishmania amazonensis treated with BZTS for 48 h.
The data are expressed as the means from three independent tests.
Additional file 3: Graphical 3. Inhibition percentage of J774A1
macrophages after treatment with BZTS for 48 h. The data are expressed
as the means from three independent tests.
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